Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmaceuticals company AbbVie (NYSE:ABBV) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at AbbVie and see what CAPS investors are saying about the stock right now.

AbbVie facts

Headquarters (founded)

North Chicago, Ill. (2012)

Market Cap

$58.3 billionĀ 



Trailing-12-Month Revenue

$18.0 billion


Chairman/CEO Richard Gonzalez
CFO William Chase

Trailing-12-Month Operating Margin



$4.6 billion / $0

Dividend Yield




Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 98% of the 108 members who have rated AbbVie believe the stock will outperform the S&P 500 going forward.

Just yesterday, one of those Fools, czheng393, offered a cautiously bullish take on AbbVie:


Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.